Simplex Trading’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-400
| Closed | – | – | 10027 |
|
|
2025
Q1 | $0 | Buy |
+400
| New | +$68 | ﹤0.01% | 10018 |
|
|
2024
Q3 | – | Sell |
-7,337
| Closed | -$3K | – | 9824 |
|
|
2024
Q2 | $3K | Buy |
7,337
+2,453
| +50% | +$1.94K | ﹤0.01% | 8198 |
|
|
2024
Q1 | $4K | Buy |
+4,884
| New | +$3.57K | ﹤0.01% | 8187 |
|
|
2023
Q4 | – | Sell |
-1,142
| Closed | -$1K | – | 10074 |
|
|
2023
Q3 | $1K | Buy |
+1,142
| New | +$1.55K | ﹤0.01% | 8462 |
|
|
2023
Q1 | – | Sell |
-237
| Closed | -$431 | – | 10374 |
|
|
2022
Q4 | $0 | Sell |
237
-8,606
| -97% | -$25.1K | ﹤0.01% | 10713 |
|
|
2022
Q3 | $37K | Buy |
8,843
+1,307
| +17% | +$5.54K | ﹤0.01% | 6833 |
|
|
2022
Q2 | $29K | Buy |
7,536
+5,083
| +207% | +$14.5K | ﹤0.01% | 7205 |
|
|
2022
Q1 | $11K | Buy |
2,453
+1,979
| +418% | +$5.96K | ﹤0.01% | 8824 |
|
|
2021
Q4 | $1K | Buy |
+474
| New | +$2.53K | ﹤0.01% | 10282 |
|
|
2020
Q3 | – | Sell |
-11
| Closed | -$96 | – | 8697 |
|
|
2020
Q2 | $0 | Buy |
+11
| New | +$166 | ﹤0.01% | 8541 |
|
|
2020
Q1 | – | Sell |
-86
| Closed | -$1.87K | – | 8431 |
|
|
2019
Q4 | $1K | Sell |
86
-1,930
| -96% | -$32.3K | ﹤0.01% | 7144 |
|
|
2019
Q3 | $50K | Buy |
2,016
+880
| +77% | +$25.4K | ﹤0.01% | 5016 |
|
|
2019
Q2 | $28K | Sell |
1,136
-452
| -28% | -$17.5K | ﹤0.01% | 5337 |
|
|
2019
Q1 | $67K | Buy |
1,588
+1,168
| +278% | +$26.5K | ﹤0.01% | 4753 |
|
|
2018
Q4 | $6K | Buy |
420
+150
| +56% | +$6.12K | ﹤0.01% | 6160 |
|
|
2018
Q3 | $18K | Buy |
270
+263
| +3,757% | +$20K | ﹤0.01% | 6053 |
|
|
2018
Q2 | $0 | Sell |
7
-148
| -95% | -$13.2K | ﹤0.01% | 7992 |
|
|
2018
Q1 | $14K | Buy |
+155
| New | +$26.6K | ﹤0.01% | 3723 |
|
|
2017
Q2 | – | Sell |
-676
| Closed | -$77.6K | – | 6926 |
|
|
2017
Q1 | $96K | Buy |
+676
| New | +$96.7K | ﹤0.01% | 1791 |
|
|
2016
Q3 | – | Sell |
-44
| Closed | -$6.21K | – | 6593 |
|
|
2016
Q2 | $5K | Sell |
44
-16
| -27% | -$1.77K | ﹤0.01% | 4297 |
|
|
2016
Q1 | $6K | Buy |
60
+4
| +7% | +$606 | ﹤0.01% | 3976 |
|
|
2015
Q4 | $10K | Sell |
56
-14
| -20% | -$2.62K | ﹤0.01% | 3323 |
|
|
2015
Q3 | $11K | Buy |
+70
| New | +$25.3K | ﹤0.01% | 3366 |
|
Simplex Trading's VIRX Position: Q2 2025 in Review
Simplex Trading sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2025, closing a stake of 400 shares.
Simplex Trading first reported a position in VIRX in Q3 2015 and held it in 23 quarters. The position peaked at $96K in Q1 2017. 0 funds tracked by Wall St. Rank hold VIRX as of Q2 2025.
- Simplex Trading reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 400 Viracta Therapeutics, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2015 and held it in 23 quarters.
- Simplex Trading's Viracta Therapeutics, Inc. Common Stock position peaked at $96K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.